
Dr Maurice Chagnaud Concludes His Tenure As Independent Director Of Torrent Pharmaceuticals
Dr Maurice Chagnaud has completed his tenure as an Independent Director of Torrent Pharmaceuticals Limited and consequently retires effective May 10, 2025.
Dr Chagnaud is a Doctor of Medicine with an MBA from IAE Aix-en-Provence, France, and has completed the Strategic Finance Program from IMD, Lausanne, Switzerland. Currently, he serves as Director on the Boards of Remedica Ltd., Cyprus, and Farmak, Ukraine. He is the Founder and CEO of Mac Healthcare Consulting AG, advising on commercial assessments, M&A, and strategy for pharma and financial sector clients. With over 27 years of senior leadership experience in the pharmaceutical industry, he has worked with companies such as Merck KGaA, Teva, Lupin, and Polpharma in roles including General Manager, Chief Commercial Officer of Europe, and CEO. Dr Chagnaud has worked on major acquisitions involving private equity firms like Bain, Blackstone, and Carlyle.